These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 12174638)
1. [Carcinoma in situ of the urinary tract--in patients with positive cytologies of upper urinary tract samples]. Kitamura Y; Kobayasi K; Suzuki K; Saito T; Komatsubara S; Watanabe M Nihon Hinyokika Gakkai Zasshi; 2002 Jul; 93(5):621-6. PubMed ID: 12174638 [TBL] [Abstract][Full Text] [Related]
2. [Intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract]. Okubo K; Ishitoya S; Maeda H; Suzuki Y; Arai Y Nihon Hinyokika Gakkai Zasshi; 1997 Mar; 88(3):386-90. PubMed ID: 9125861 [TBL] [Abstract][Full Text] [Related]
3. Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract. Nonomura N; Ono Y; Nozawa M; Fukui T; Harada Y; Nishimura K; Takaha N; Takahara S; Okuyama A Eur Urol; 2000 Dec; 38(6):701-4;discussion 705. PubMed ID: 11111187 [TBL] [Abstract][Full Text] [Related]
4. Intravesical instillation of bacille Calmette-Guérin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter. Irie A; Iwamura M; Kadowaki K; Ohkawa A; Uchida T; Baba S Urology; 2002 Jan; 59(1):53-7. PubMed ID: 11796281 [TBL] [Abstract][Full Text] [Related]
5. Intrarenal bacillus Calmette-Guérin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure. Okubo K; Ichioka K; Terada N; Matsuta Y; Yoshimura K; Arai Y BJU Int; 2001 Sep; 88(4):343-7. PubMed ID: 11564018 [TBL] [Abstract][Full Text] [Related]
6. Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary bladder: can post-induction random bladder biopsies be avoided? Smith PJ; Lotan Y; Raj GV; Sagalowsky AI; Margulis V Cytopathology; 2014 Apr; 25(2):108-11. PubMed ID: 23551700 [TBL] [Abstract][Full Text] [Related]
7. Bacillus Calmette-Guérin instillation treatment for carcinoma in situ of the upper urinary tract. Nishino Y; Yamamoto N; Komeda H; Takahashi Y; Deguchi T BJU Int; 2000 May; 85(7):799-801. PubMed ID: 10792155 [TBL] [Abstract][Full Text] [Related]
8. [The diagnosis and treatment for carcinoma in situ of the bilateral upper urinary tracts after total cystectomy and ileal conduit by intentionally inducing hydronephrosis]. Saito J; Kato T; Kakuta Y; Tanaka M; Yazawa K; Hosomi M; Ito K Hinyokika Kiyo; 2006 Jul; 52(7):573-5. PubMed ID: 16910594 [TBL] [Abstract][Full Text] [Related]
9. [Clinical observation of 8 cases of carcinoma in situ of the urinary bladder]. Murase T; Ito H; Ohishi M; Takashi M Hinyokika Kiyo; 1989 Apr; 35(4):583-5. PubMed ID: 2735263 [TBL] [Abstract][Full Text] [Related]
11. Analysis of early failures after intravesical instillation therapy with bacille Calmette-Guérin for carcinoma in situ of the bladder. Merz VW; Marth D; Kraft R; Ackermann DK; Zingg EJ; Studer UE Br J Urol; 1995 Feb; 75(2):180-4. PubMed ID: 7850322 [TBL] [Abstract][Full Text] [Related]
12. [Intrarenal Bacillus Calmette-Guerin perfusion therapy was effective for carcinoma in situ of the upper urinary tract after ileal conduit replacement : a case report]. Hayashi T; Yamanaka Y; Kinjo T; Katayama K; Kamoto A; Mori N; Yoshioka T Hinyokika Kiyo; 2014 Apr; 60(4):175-8. PubMed ID: 24882229 [TBL] [Abstract][Full Text] [Related]
13. [Intravesical bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the urinary bladder and prediction of effects by urinary cytologic examination]. Satoh E; Arai H; Gotoh T; Miura H; Honda M; Fujioka H; Uraoka T; Tsujimoto M Nihon Hinyokika Gakkai Zasshi; 1999 Dec; 90(12):901-5. PubMed ID: 10658461 [TBL] [Abstract][Full Text] [Related]
14. [Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder. Gifu BCG Instillation Therapy Research Group]. Nishino Y; Yasuda M; Yokoi S; Ehara H; Yamamoto N; Takahashi Y; Ishihara S; Deguchi T; Kawada Y; Takeda A; Sakai S; Takeuchi T; Taniguchi M; Minoshima K; Hamamoto Y; Kanimoto Y; Nakano M; Fujihiro S; Nezasa S; Matsuda T; Nagatani Y; Maeda S; Tamaki M; Saito A; Komeda H Gan To Kagaku Ryoho; 1999 Oct; 26(12):1869-73. PubMed ID: 10560414 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of intrarenal Bacillus Calmette-Guérin/interferon-α2B for biopsy-proven upper-tract carcinoma in situ. Shapiro EY; Lipsky MJ; Cha DY; McKiernan JM; Benson MC; Gupta M J Endourol; 2012 Dec; 26(12):1645-50. PubMed ID: 22834939 [TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of intravesical bacillus Calmette-Guérin therapy with maintenance for urinary bladder carcinoma in situ: About 47 cases. Sallami S; Khouni H; Ben Atta M; Abou El Makarim S; Zouari MB; Ben Rhouma S Tunis Med; 2016 Dec; 94(12):844. PubMed ID: 28994883 [TBL] [Abstract][Full Text] [Related]
18. [Progression and recurrence in the prostate and upper urinary tract following intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer]. Wakabayashi Y; Okada Y; Mukumoto K; Hamaguchi A; Konishi T; Tomoyoshi T Nihon Hinyokika Gakkai Zasshi; 1993 Dec; 84(12):2146-51. PubMed ID: 8309122 [TBL] [Abstract][Full Text] [Related]